Cytokine gene polymorphism and heart transplant rejection

Transplantation

Volumn 64, Issue 5, 1997, Pages 776-779

  Turner, David ^a   Grant, Simon C D ^b   Yonan, Nizar ^b   Sheldon, Stephen ^a   Dyer, Philip A ^a   Sinnott, Paul J ^a   Hutchinson, Ian V ^c  

^a ST MARY S HOSPITAL   (United Kingdom)

^b WYTHENSHAWE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; CYTOKINE; DNA; HLA DR ANTIGEN; INTERLEUKIN 10; PREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA DETERMINATION; DNA POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; GRAFT REJECTION; HEART TRANSPLANTATION; HLA TYPING; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; RECIPIENT;

CYTOKINES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; INTERLEUKIN-10; POLYMORPHISM, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030930830     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199709150-00021     Document Type: Article

References (10)

1. Sayegh MH, Watschinger B, Carpenter CB. Mechanisms of T cell recognition of alloantigen. The role of peptides. Transplantation 1994; 57: 1295.
2. Sheldon S, Hasleton PS, Yonan NA, et al. Rejection in heart transplantation strongly correlates with HLA-DR antigen mismatch. Transplantation 1994; 58: 719.
3. Pober JS, Cotran RS. The role of endothelial cells in inflammation. Transplantation 1990; 50: 537.
4. Chollet-Martin S, Depoix JP, Hvass U, Pansard C, Vissuzaine C, Gougerot-Pocidalo MA. Raised plasma levels of tumor necrosis factor in heart allograft rejection. Transplant Proc 1990; 22: 283-286.
5. Mosmann TR. Properties and functions of interleukin-10. Adv Immunol 1994; 56: 1.
6. Bromberg JS. Il-10 immunosuppression in transplantation. Curr Opin Immunol 1995; 7: 639.
7. Wilson AG, di Giovine FS, Blakemore AIF, Duff GW. Single base polymorphism in the human tumour necrosis factor alpha (TNFα) gene detectable by NcoI restriction of PCR product. Hum Mol Genet 1992; 1: 353.
8. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogen 1997; 24: 1.
9. Wilson AG, Symons JA, McDowell TL, di Giovine FS, Duff GW. Effects of a tumour necrosis factor (TNFα) promoter base transition on transcriptional activity. Br J Rheumatol 1994; 33(suppl): 1: 89.
10. Danis VA, Millington M, Hyland VJ, Grennan D. Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism. Clin Exp Immunol 1995; 99: 303.